China Covid Vaccines

The Chinese authorities are rushing to push out vaccines to combat an ongoing new wave of the coronavirus that is expected to peak in June and infect as many as 65 million people a week.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.

Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.

The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing's relaxation of its "zero-COVID" policies.

PK Mishra, Principal Secretary to the prime minister, chaired the meeting with senior officials and experts

India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.

China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.

As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.

The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.

The head of the World Health Organization on Wednesday said he was "very concerned" about an unprecedented wave of Covid cases in China, as the health body urged Beijing to accelerate vaccination of the most vulnerable.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

Between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity, according to London-based global health intelligence and analytics firm.

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools.

The Chinese authorities are rushing to push out vaccines to combat an ongoing new wave of the coronavirus that is expected to peak in June and infect as many as 65 million people a week.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.

Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.

The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing's relaxation of its "zero-COVID" policies.

PK Mishra, Principal Secretary to the prime minister, chaired the meeting with senior officials and experts

India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.

China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.

As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.

The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.

The head of the World Health Organization on Wednesday said he was "very concerned" about an unprecedented wave of Covid cases in China, as the health body urged Beijing to accelerate vaccination of the most vulnerable.

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".

Between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity, according to London-based global health intelligence and analytics firm.

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools.